Jiangsu Yahong Meditech CoSHSE:688176 +0.92%48 Current Ratio is 4.07 as of Mar. 2026, which is 68% below its 10-year median of 12.82. GuruFocus rates SHSE:688176 with a GF Score™ of 48/100 and a GF Value™ of ¥18.39 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 998 Drug Manufacturers companies, Jiangsu Yahong Meditech Co ranks better than 78.56% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Jiangsu Yahong Meditech Co's current ratio for the quarter that ended in Mar. 2026 was 4.07.
Jiangsu Yahong Meditech Co has a current ratio of 4.07. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Jiangsu Yahong Meditech Co's Current Ratio or its related term are showing as below:
SHSE:688176'
s Current Ratio Range Over the Past 10 Years
Min: 1.4 Med: 12.82 Max: 59.26
Current: 4.07
During the past 8 years, Jiangsu Yahong Meditech Co's highest Current Ratio was 59.26. The lowest was 1.40. And the median was 12.82.
SHSE:688176's Current Ratio is ranked better than 78.56% of 998
companies
in the Drug Manufacturers industry
Industry Median: 2
vs SHSE:688176: 4.07
Jiangsu Yahong Meditech Co (SHSE:688176) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Jiangsu Yahong Meditech Co Current Ratio Related Terms
Jiangsu Yahong Meditech Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688176 vs ZTS, UTHR: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Yahong Meditech Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Yahong Meditech Co Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Yahong Meditech Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Jiangsu Yahong Meditech Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Yahong Meditech Co (SHSE:688176) has a Current Ratio of 4.07 as of Mar. 2026. This is 68% below median its historical median of 12.82. Over the past decade, Jiangsu Yahong Meditech Co's Current Ratio has ranged from 1.40 to 59.26. According to the industry distribution chart, Jiangsu Yahong Meditech Co ranks #214 out of 998 companies in the Drug Manufacturers industry, placing it in the top 21.4%.
Is Jiangsu Yahong Meditech Co's Current Ratio too high?
Jiangsu Yahong Meditech Co's current Current Ratio of 4.07 is 68% below median its 10-year median of 12.82. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 59.26. The Drug Manufacturers industry median Current Ratio is 2.00. Jiangsu Yahong Meditech Co's value of 4.07 is 103.5% above this industry median. Based on the distribution chart, Jiangsu Yahong Meditech Co ranks #214 out of 998 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangsu Yahong Meditech Co has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Yahong Meditech Co's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Yahong Meditech Co ranks #214 out of 998 companies for Current Ratio. This places Jiangsu Yahong Meditech Co in the top 21% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.00. Jiangsu Yahong Meditech Co's value of 4.07 is 103.5% above this benchmark. Historically, Jiangsu Yahong Meditech Co's own Current Ratio has ranged from 1.40 to 59.26 over the past decade. While the company's 10-year median is 12.82 vs. the industry median of 2.00, Jiangsu Yahong Meditech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Yahong Meditech Co's current Current Ratio of 4.07 is 103.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Yahong Meditech Co's current Current Ratio is 4.07, which is 68% below median its own 10-year median of 12.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Yahong Meditech Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Yahong Meditech Co (SHSE:688176) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥18.39, compared to a current price of ¥13.22 — trading 28.1% below its estimated fair value. The current Current Ratio is 4.07, which is 68% below median its 10-year median of 12.82 and 103.5% above the Drug Manufacturers industry median of 2.00. Jiangsu Yahong Meditech Co's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Jiangsu Yahong Meditech Co (SHSE:688176), the current Current Ratio is 4.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Yahong Meditech Co (SHSE:688176) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Yahong Meditech Co stock appears to be undervalued.
The current stock price of ¥13.22 is trading 28.1% below its estimated GF Value™ of ¥18.39.
GuruFocus considers Jiangsu Yahong Meditech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688176:
Current Ratio: 4.07 (68% below median its 10-year median of 12.82)
GF Value™: ¥18.39 vs. price of ¥13.22 (28.1% below fair value)
Industry Position: 103.5% above the Drug Manufacturers median (#214 of 998)
No single metric tells the full story. See the SHSE:688176 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Yahong Meditech Co Ltd is a pharmaceutical company integrating research and development, production and commercialization in the field of focused treatment, providing the integration of diagnosis and treatment for Chinese and global patients Solutions.
48GF Score
Get the complete analysis for SHSE:688176
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688176 has been successfully added to your 
